Recent developments in plant-derived edible nanoparticles as therapeutic nanomedicines
Neha Jain
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
Search for more papers by this authorCorresponding Author
Manisha Pandey
Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh, 123031 India
Correspondence
Manisha Pandey, Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh 123031, India.
Email: [email protected]
Gaurav Gupta, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, India.
Email: [email protected]
Search for more papers by this authorPalak Sharma
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
Search for more papers by this authorCorresponding Author
Gaurav Gupta
School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India
Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India
Correspondence
Manisha Pandey, Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh 123031, India.
Email: [email protected]
Gaurav Gupta, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, India.
Email: [email protected]
Search for more papers by this authorBapi Gorain
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India
Search for more papers by this authorKamal Dua
Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, 2007 Australia
Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, New South Wales, Australia
Search for more papers by this authorNeha Jain
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
Search for more papers by this authorCorresponding Author
Manisha Pandey
Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh, 123031 India
Correspondence
Manisha Pandey, Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh 123031, India.
Email: [email protected]
Gaurav Gupta, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, India.
Email: [email protected]
Search for more papers by this authorPalak Sharma
Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India
Search for more papers by this authorCorresponding Author
Gaurav Gupta
School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India
Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India
Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India
Correspondence
Manisha Pandey, Department of Pharmaceutical Sciences, Central University of Haryana, Mahendergarh 123031, India.
Email: [email protected]
Gaurav Gupta, School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, India.
Email: [email protected]
Search for more papers by this authorBapi Gorain
Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, India
Search for more papers by this authorKamal Dua
Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, New South Wales, 2007 Australia
Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, New South Wales, Australia
Search for more papers by this authorAbstract
The use of nanotechnology in the treatment of numerous disorders has proven effective. The predicted development of plant-derived edible nanoparticles (PDNPs) as potential therapeutic agents for treating illness or in the delivery of drugs is inevitable. PDNPs generated from plants resemble mammal-extracted exosomes structurally. In contrast to their excellent biocompatibility with healthy cells, PDNPs are skewed toward malignancies by selectively targeting those cells via unique endocytic pathways. They can be generated in large quantities, are nontoxic, and have tissue-specific targeting abilities. Thus, with fewer off-target effects, using these PDNPs could broaden the breadth of pharmacological therapy. In this discussion, we emphasize the properties and biological activities of PDNPs isolated from fruits and vegetables and discuss the promising implications of these particles as nanomedicines.
Practical applications
PDNPs have reportedly been employed for therapeutic applications for several ailments and are believed to have characteristics in common with exosomes generated from mammals. The advantages of PDNPs over mammalian-derived exosomes are numerous. Firstly, they may be produced on a commercial scale using a variety of efficient renewable sources. Secondly, the PDNPs' natural components developed in plant cells promise improved cytocompatibility, tolerability, low cytotoxicity, or other adverse effects. We evaluated some current studies on the applications and potential of PDNPs in this article. PDNPs could create new opportunities for drug discovery because of recent advancements in medicine and drug delivery system nanotechnology. Unfortunately, the precise mechanisms behind PDNP's functions and interaction in pathogenic processes have not yet been completely elucidated; as a result, the potential consequences of their clinical use are uncertain. Overall, PDNPs show a wide range of therapeutic possibilities that may be advantageous to patients and might eventually make up the next generation of pharmaceuticals.
CONFLICT OF INTEREST
The author declares no conflicts of interest.
Open Research
DATA AVAILABILITY STATEMENT
Peer review of empirical data will be conducted to confirm that the data reproduce the analytic results reported in the paper.
REFERENCES
- Cao, M., Yan, H., Han, X., Weng, L., Wei, Q., Sun, X., Lu, W., Wei, Q., Ye, J., Cai, X., Hu, C., Yin, X., & Cao, P. (2019). Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. Journal for Immuno Therapy of Cancer, 7(1), 326–344. https://doi.org/10.1186/s40425-019-0817-4
- Chandran, S. P., Chaudhary, M., Pasricha, R., Ahmad, A., & Sastry, M. (2006). Synthesis of gold nanotriangles and silver nanoparticles using aloevera plant extract. Biotechnol Progress, 22, 577–583. https://doi.org/10.1021/bp0501423
- Deng, Z., Rong, Y., Teng, Y., Mu, J., Zhuang, X., Tseng, M., Samykutty, A., Zhang, L., Yan, J., Miller, D., Suttles, J., & Zhang, H. G. (2017). Broccoli-derived nanoparticle inhibits mouse colitis by activating dendritic cell AMP-activated protein kinase. Molecular Therapy, 25(7), 1641–1654. https://doi.org/10.1016/j.ymthe.2017.01.025
- Di Gioia, S., Hossain, M. N., & Conese, M. (2020). Biological properties and therapeutic effects of plant-derived nanovesicles. Open Medicine (Warsaw, Poland), 15(1), 1096–1122. https://doi.org/10.1515/med-2020-0160
- Dryden, G. W. (2011). Study investigating the ability of plant exosomes to deliver curcumin to normal and colon cancer tissue. Clinicaltrials.Gov.
- Fernández-Ruiz, M., & Aguado, J. M. (2018). Risk of infection associated with anti-TNF-α therapy. Expert Review of Anti-Infective Therapy, 16(12), 939–956. https://doi.org/10.1080/14787210.2018.1544490
- Gareb, B., Otten, A. T., Frijlink, H. W., Dijkstra, G., & Kosterink, J. G. W. (2020). Local tumor necrosis factor-α inhibition in inflammatory bowel disease. Pharmaceutics, 12(6), 539. https://doi.org/10.3390/PHARMACEUTICS12060539
- Graham, J., Cancer, B., & Redman, R. (2012). Edible plant exosome ability to prevent oral mucositis associated with chemoradiation treatment of head and neck cancer. Clinicaltrials.Gov, (August).
- Ha, D., Yang, N., & Nadithe, V. (2016). Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: Current perspectives and future challenges. Acta Pharmaceutica Sinica B, 6, 287–296. https://doi.org/10.1016/j.apsb.2016.02.001
- Ju, S., Mu, J., Dokland, T., Zhuang, X., Wang, Q., Jiang, H., Xiang, X., Deng, Z.-B., Wang, B., Zhang, L., Roth, M., Welti, R., Mobley, J., Jun, Y., Miller, D., & Zhang, H. G. (2013). Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Molecular Therapy, 21(7), 1345–1357. https://doi.org/10.1038/mt.2013.64
- Kalarikkal, S. P., & Sundaram, G. M. (2021). Edible plant-derived exosomal microRNAs: Exploiting a cross-kingdom regulatory mechanism for targeting SARS-CoV-2. Toxicology and Applied Pharmacology, 414, 115425. https://doi.org/10.1016/j.taap.2021.115425
- Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016). Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proceedings of the National Academy of Sciences of the United States of America, 113(8), E968–E977. https://doi.org/10.1073/pnas.1521230113
- Li, X., Liang, Z., Du, J., Wang, Z., Mei, S., Li, Z., Zhao, Y., Zhao, D., Ma, Y., Ye, J., Xu, J., Zhao, Y., Chang, J., Qin, Y., Yu, L., Wang, C., & Jiang, C. (2019). Herbal decoctosome is a novel form of medicine. Science China Life Sciences, 62(3), 333–348. https://doi.org/10.1007/s11427-018-9508-0
- Loureiro, J. A., Andrade, S., Duarte, A., Neves, A. R., Queiroz, J. F., Nunes, C., Sevin, E., Fenart, L., Gosselet, F., Coelho, M. A., & Pereira, M. C. (2017). Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer's disease. Molecules, 22(2), 277–293. https://doi.org/10.3390/molecules22020277
- Mathivanan, S., Fahner, C. J., Reid, G. E., & Simpson, R. J. (2012). ExoCarta 2012: Database of exosomal proteins, RNA and lipids. Nucleic Acids Research, 40(D1), D1241–D1244. https://doi.org/10.1093/nar/gkr828
- Milcovich, G., Lettieri, S., Antunes, F. E., Medronho, B., Fonseca, A. C., Coelho, J. F. J., Marizza, P., Perrone, F., Farra, R., Dapas, B., Grassi, G., Grassi, M., & Giordani, S. (2017). Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot. Advances in Colloid and Interface Science, 249, 163–180. https://doi.org/10.1016/j.cis.2017.05.009
- Mu, J., Zhuang, X., Wang, Q., Jiang, H., Deng, Z. B., Wang, B., Zhang, L., Kakar, S., Jun, Y., Miller, D., & Zhang, H. G. (2014). Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Molecular Nutrition and Food Research, 58(7), 1561–1573. https://doi.org/10.1002/mnfr.201300729
- Pérez-Bermúdez, P., Blesa, J., Soriano, J. M., & Marcilla, A. (2017). Extracellular vesicles in food: Experimental evidence of their secretion in grape fruits. European Journal of Pharmaceutical Sciences, 98, 40–50. https://doi.org/10.1016/j.ejps.2016.09.022
- Raimondo, S., Naselli, F., Fontana, S., Monteleone, F., Lo Dico, A., Saieva, L., Zito, G., Flugy, A., Manno, M., Di Bella, M. A., De Leo, G., & Alessandro, R. (2015). Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death. Oncotarget, 6(23), 19514–19527. https://doi.org/10.18632/oncotarget.4004
- Raimondo, S., Nikolic, D., Conigliaro, A., Giavaresi, G., Lo Sasso, B., Giglio, R. V., Chianetta, R., Manno, M., Raccosta, S., Corleone, V., Ferrante, G., Citarrella, R., Rizzo, M., De Leo, G., Ciaccio, M., Montalto, G., & Alessandro, R. (2021). Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study. Metabolites, 11(5), 276–290. https://doi.org/10.3390/metabo11050276
- Rome, S. (2019). Biological properties of plant-derived extracellular vesicles. Food and Function, 10(2), 529–538. https://doi.org/10.1039/c8fo02295j
- Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015). Advances and challenges of liposome assisted drug delivery. Frontiers in Pharmacology, 6, 286. https://doi.org/10.3389/FPHAR.2015.00286
- Shah, A., Aftab, S., Nisar, J., Ashiq, M. N., & Iftikhar, F. J. (2021). Nanocarriers for targeted drug delivery. Journal of Drug Delivery Science and Technology, 62, 102426. https://doi.org/10.1016/J.JDDST.2021.102426
- Skotland, T., Sandvig, K., & Llorente, A. (2017). Lipids in exosomes: Current knowledge and the way forward. Progress in Lipid Research, 66, 30–41. https://doi.org/10.1016/j.plipres.2017.03.001
- Stremersch, S., de Smedt, S. C., & Raemdonck, K. (2016). Therapeutic and diagnostic applications of extracellular vesicles. Journal of Controlled Release, 244, 167–183. https://doi.org/10.1016/j.jconrel.2016.07.054
- Suresh, A. P., Kalarikkal, S. P., Pullareddy, B., & Sundaram, G. M. (2021). Low pH-based method to increase the yield of plant-derived nanoparticles from fresh ginger rhizomes. ACS omega, 6(27), 17635–17641. https://doi.org/10.1021/acsomega.1c02162
- Ukidave, V. V., & Ingale, L. T. (2022). Green synthesis of zinc oxide nanoparticles from Coriandrum sativum and their use as fertilizer on Bengal gram, Turkish gram, and green gram plant growth. International Journal of Agronomy, 2022(8), 1–14. https://doi.org/10.1155/2022/8310038
- van der Meel, R., Fens, M. H. A. M., Vader, P., van Solinge, W. W., Eniola-Adefeso, O., & Schiffelers, R. M. (2014). Extracellular vesicles as drug delivery systems: Lessons from the liposome field. Journal of Controlled Release, 195, 72–85. https://doi.org/10.1016/j.jconrel.2014.07.049
- Wang, S., Cheng, K., Chen, K., Xu, C., Ma, P., Dang, G., Yang, Y., Lei, Q., Huang, H., Yu, Y., Fang, Y., Tang, Q., Jiang, N., Miao, H., Liu, F., Zhao, X., & Li, N. (2022). Nanoparticle-based medicines in clinical cancer therapy. Nano Today, 45, 101512. https://doi.org/10.1016/J.NANTOD.2022.101512
- Wang, B., Zhuang, X., Deng, Z. B., Jiang, H., Mu, J., Wang, Q., Xiang, X., Guo, H., Zhang, L., Dryden, G., Yan, J., Miller, D., & Zhang, H. G. (2014). Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Molecular Therapy, 22(3), 522–534. https://doi.org/10.1038/mt.2013.190
- Wang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., & Zhang, H. G. (2015). Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Research, 75(12), 2520–2529. https://doi.org/10.1158/0008-5472.CAN-14-3095
- Wang, Q., Zhuang, X., Mu, J., Deng, Z. B., Jiang, H., Zhang, L., Xiang, X., Wang, B., Yan, J., Miller, D., & Zhang, H. G. (2013). Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nature Communications, 4, 1867. https://doi.org/10.1038/ncomms2886
- Xiao, J., Feng, S., Wang, X., Long, K., Luo, Y., Wang, Y., Ma, J., Tang, Q., Jin, L., Li, X., & Li, M. (2018). Identification of exosome-like nanoparticle-derived microRNAs from 11 edible fruits and vegetables. PeerJ, 2018(7), e5186. https://doi.org/10.7717/PEERJ.5186/SUPP-7
- Yang, C., Zhang, M., & Merlin, D. (2018). Advances in plant-derived edible nanoparticle-based lipid nano-drug delivery systems as therapeutic nanomedicines. Journal of Materials Chemistry B, 6, 1312–1321. https://doi.org/10.1039/c7tb03207b
- Yu, L., Deng, Z., Liu, L., Zhang, W., & Wang, C. (2020). Plant-Derived Nanovesicles: A Novel Form of Nanomedicine. Front. Bioeng. Biotechnol., 8, 584391. https://doi.org/10.3389/fbioe.2020.584391
- Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., & Merlin, D. (2016). Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials, 101, 321–340. https://doi.org/10.1016/j.biomaterials.2016.06.018
- Zhang, M., Viennois, E., Xu, C., & Merlin, D. (2016). Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers, 4, e1134415. https://doi.org/10.1080/21688370.2015.1134415
- Zhang, M., Wang, X., Han, M. K., Collins, J. F., & Merlin, D. (2017). Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine, 12(16), 1927–1943. https://doi.org/10.2217/nnm-2017-0196
- Zhang, M., Xiao, B., Wang, H., Han, M. K., Zhang, Z., Viennois, E., Xu, C., & Merlin, D. (2016). Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Molecular Therapy, 24(10), 1783–1796. https://doi.org/10.1038/mt.2016.159
- Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., & Merlin, D. (2016). Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials, 101, 321–340. https://doi.org/10.1016/j.biomaterials.2016.06.018
- Zhuang, X., Teng, Y., Samykutty, A., Mu, J., Deng, Z., Zhang, L., Cao, P., Rong, Y., Yan, J., Miller, D., & Zhang, H. G. (2016). Grapefruit-derived nanovectors delivering therapeutic miR17 through an intranasal route inhibit brain tumor progression. Molecular Therapy : The Journal of the American Society of Gene Therapy, 24(1), 96–105. https://doi.org/10.1038/MT.2015.188
- Zu, M., Song, H., Zhang, J., Chen, Q., Deng, S., Canup, B. S. B., Yuan, Y., & Xiao, B. (2020). Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis. Colloids and Surfaces. B, Biointerfaces, 187, 110747. https://doi.org/10.1016/J.COLSURFB.2019.110747
- Zylberberg, C., & Matosevic, S. (2016). Pharmaceutical liposomal drug delivery: A review of new delivery systems and a look at the regulatory landscape. Drug Delivery, 23, 3319–3329. https://doi.org/10.1080/10717544.2016.1177136
